Skip Nav Destination
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities
RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma
The etiology of severe anemia in a village and a periurban area in Mali
New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Issue Archive
August 15 2004
Table of Contents
INSIDE BLOOD
PERSPECTIVES
REVIEW ARTICLES
RETRACTIONS
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
Clinical Trials & Observations
Steven G. Deeks,Christina M. R. Kitchen,Lea Liu,Hua Guo,Ron Gascon,Amy B. Narváez,Peter Hunt,Jeffrey N. Martin,James O. Kahn,Jay Levy,Michael S. McGrath,Frederick M. Hecht
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration
Clinical Trials & Observations
Geoff Hale,Peppy Rebello,Lee R. Brettman,Chris Fegan,Ben Kennedy,Eva Kimby,Mike Leach,Jeanette Lundin,Håkan Mellstedt,Paul Moreton,Andy C. Rawstron,Herman Waldmann,Anders Osterborg,Peter Hillmen
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities
Clinical Trials & Observations
Mohamed L. Sorror,Michael B. Maris,Barry Storer,Brenda M. Sandmaier,Razvan Diaconescu,Christopher Flowers,David G. Maloney,Rainer Storb
GENE THERAPY
HEMATOPOIESIS
Indian hedgehog gene transfer augments hematopoietic support of human stromal cells including NOD/SCID–ß2m–/– repopulating cells.
Masayoshi Kobune,Yoshinori Ito,Yutaka Kawano,Katsunori Sasaki,Hiroaki Uchida,Kiminori Nakamura,Hironari Dehari,Hiroki Chiba,Rishu Takimoto,Takuya Matsunaga,Takeshi Terui,Junji Kato,Yoshiro Niitsu,Hirofumi Hamada
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia
Rainer Kunstfeld,Satoshi Hirakawa,Young-Kwon Hong,Vivien Schacht,Bernhard Lange-Asschenfeldt,Paula Velasco,Charles Lin,Edda Fiebiger,Xunbin Wei,Yan Wu,Daniel Hicklin,Peter Bohlen,Michael Detmar
IMMUNOBIOLOGY
NEOPLASIA
Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels
Katja Specht,Eugenia Haralambieva,Karin Bink,Marcus Kremer,Sonja Mandl-Weber,Ina Koch,Raju Tomer,Heinz Hofler,Ed Schuuring,Philip M. Kluin,Falko Fend,Leticia Quintanilla-Martinez
Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody
Yiwen Li,Hongli Li,Mei-Nai Wang,Dan Lu,Rajiv Bassi,Yan Wu,Haifan Zhang,Paul Balderes,Dale L. Ludwig,Bronislaw Pytowski,Paul Kussie,Obdulio Piloto,Donald Small,Peter Bohlen,Larry Witte,Zhenping Zhu,Daniel J. Hicklin
RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma
Clinical Trials & Observations
Christopher A. Maxwell,Erik Rasmussen,Fenghuang Zhan,Jonathan J. Keats,Sophia Adamia,Erin Strachan,Mary Crainie,Ronald Walker,Andrew R. Belch,Linda M. Pilarski,Bart Barlogie,John Shaughnessy, Jr,Tony Reiman
PHAGOCYTES
RED CELLS
The etiology of severe anemia in a village and a periurban area in Mali
Clinical Trials & Observations
Brief Report
Alassane Dicko,Amy D. Klion,Mahamadou A. Théra,Issaka Sagara,Daniel Yalcouyé,Mohamed B. Niambele,Moussa Sogoba,Guimogo Dolo,Adama Dao,Dapa A. Diallo,Ogobara K. Doumbo,Louis H. Miller
TRANSPLANTATION
New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years
Clinical Trials & Observations
Pietro Sodani,David Gaziev,Paola Polchi,Buket Erer,Claudio Giardini,Emanuele Angelucci,Donatella Baronciani,Marco Andreani,Marisa Manna,Sonia Nesci,Barbarella Lucarelli,Reginald A. Clift,Guido Lucarelli
Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets
Matthias Stelljes,Robert Strothotte,Hans-Gerd Pauels,Christopher Poremba,Michaela Milse,Christiane Specht,Jörn Albring,Guido Bisping,Christian Scheffold,Thomas Kammertoens,Elisabeth Oelmann,Gerda Silling,Wolfgang E. Berdel,Joachim Kienast
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Brief Report
Vincent T. Ho,David Zahrieh,Ephraim Hochberg,Eileen Micale,Jesse Levin,Carol Reynolds,Steve Steckel,Corey Cutler,David C. Fisher,Stephanie J. Lee,Edwin P. Alyea,Jerome Ritz,Robert J. Soiffer,Joseph H. Antin
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals